DUBLIN–(BUSINESS WIRE)–The “Global Psoriasis Treatment Market – Analysis by Type, by Treatment Method, by Region, by Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)” report has been added to ResearchAndMarkets.com’s offering.
Global Psoriasis Treatment Market was valued at USD 16.7 billion in the year 2019.
Rising prevalence of psoriasis affected people, rise in research and investments in developing biological treatment, rise in awareness of psoriasis coupled with the rising demand for healthcare products are the major factors impelling the market growth. Major growth in the forecast period is likely to be demonstrated from the various drugs that are in the clinical stages and would be available commercially in the next 3-5 years. This includes among others, the most promising ARQ-154 Foam for scalp psoriasis, from the US biotechnology company, Arcutis, which has the potential to become a billion-dollar opportunity for the treatment of psoriasis.
Genetic disposition, rising geriatric population and increasing government initiatives creating psoriasis awareness have been anticipated to infuse growth in the market for Psoriasis during the forecasting period of 2020-2025. Factors such as rising geriatric population, practice of unhealthy lifestyle such as heavy consumption of alcohol, smoking tobacco, enaction of immunity framework, stress and sunburn are crucial factors are supposed to trigger Psoriasis and Psoriasis arthritis that is consequently accelerating the demand for Psoriasis treatment and medication.
The growth of the market is hampered in 2020 due to the occurrence of coronavirus pandemic in which all worldwide business activities are put at hold for the first few months of the year. IPC recommended physicians to discontinue or postpone use of immunosuppressant medications for the psoriasis patients, which is negatively affecting the Psoriasis drugs market growth. However, as per National Psoriasis Foundation the Medicare extended its inclusion of telehealth administrations in amid COVID-19 pandemic due to which the treatment has been resumed and the drug market has been supported in few first few months of 2020 that are anticipated to recover and accelerate the demand for the treatment in the coming years.
Under the Type Segment, Plaque Psoriasis is the most common type of psoriasis and dominates the overall psoriasis market. The developing number of advanced medicines for the treatment of plaque psoriasis by the key players is augmenting the demand for enhanced medication.
The continual research and development in a number of biologics and biosimilars by the drug developing companies are expected to propel market demand of biologics treatment method for psoriasis. Among the regions, North America is followed by and Europe and Asia Pacific. Asia Pacific region is the most attractive region for the growth of Psoriasis treatment owing large targeted population base coupled with increasing healthcare spending, prevalence of psoriasis or psoriatic arthritis patients, rise in government contribution and awareness programs.
Scope of the Report
- The report analyses Psoriasis market By Value
- The report analyses Psoriasis Market By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis)
- The report assesses the Psoriasis market By Treatment Method – (Biologics, Systemic Treatment, Topical Treatment, Others).
- The Global Psoriasis Market has been analysed By Region (North America, Europe, Asia Pacific) and By Country (US, Canada, Norway, UK, Spain, Germany, China, India, South Korea, Japan).
- The key insights of the report have been presented through the attractiveness of the market has been presented By Type, By Treatment Method and By Region. Additionally, the major opportunities, trends, drivers, challenges and pipeline products of the industry has been analysed in the report.
- The companies analysed in the report include UCB, Sun Pharmaceutical Industries LTD, Boehringer Ingelheim, Almirall, Bausch Health, Abbvie Inc, Eli Lilly and Company, Pfizer Inc., Amgen Inc., Johnson & Johnson.
- The report presents the analysis of Psoriasis market for the historical period of 2015-2019 and the forecast period of 2020-2025.
Key Topics Covered
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Psoriasis Treatment Market: Product Outlook
4. Global Psoriasis Treatment Market: Sizing, Growth and Forecast
4.1 Market Size, By Value, Year 2015-2025
5. Global Psoriasis Treatment Market Segmentation By Type (By Value)
5.1 Competitive Scenario of Global Psoriasis Market – By Type (2019 & 2025)
5.2 Plaque Psoriasis- Market Size and Forecast (2020-2025)
5.3 Inverse Psoriasis- Market Size and Forecast (2020-2025)
5.4 Guttate Psoriasis- Market Size and Forecast (2020-2025)
5.5 Pustular Psoriasis- Market Size and Forecast (2020-2025)
5.6 Erythrodermic Psoriasis- Market Size and Forecast (2020-2025)
6. Global Psoriasis Market Segmentation By Treatment Method (By Value)
6.1 Competitive Scenario of Global Psoriasis – By Treatment Method (2019 & 2025)
6.2 Biologics – Market Size and Forecast (2020-2025)
6.3 Systemic Treatment- Market Size and Forecast (2020-2025)
6.4 Topical Treatment- Market Size and Forecast (2020-2025)
6.5 Others – Market Size and Forecast (2020-2025)
7. Global Psoriasis Treatment Market: Regional Analysis
7.1 Competitive Scenario of Global Psoriasis Market : By Region (2019 & 2025)
8. North America Psoriasis Market: Segmentation By Type, By Treatment Method (2020-2025)
8.1 North America Psoriasis Treatment Market: Size and Forecast (2020-2025)
8.2 North America Prominent Companies in Psoriasis Market
8.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
8.4 Market Segmentation By Treatment Method (Biologics, Systemic Treatment, Topical Treatment & Others)
8.5 North America Psoriasis Market: Country Analysis
8.6 Market Opportunity Chart of North America Psoriasis Market – By Country, By Value (Year-2025)
8.7 Competitive Scenario of North America Psoriasis Market: By Country (2019 & 2025)
8.8 United States Psoriasis Market: Size and Forecast (2020-2025)
8.9 United States Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
8.10 Canada Psoriasis Market: Size and Forecast (2020-2025)
8.11 Canada Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
9. Europe Psoriasis Market: Segmentation By Type, By Treatment Method (2020-2025)
10. Asia Pacific Psoriasis Market: Segmentation By Type, By Treatment Method (2020-2025)
11. Global Psoriasis Treatment Market Dynamics
11.1 Global Psoriasis Market Drivers
11.2 Global Psoriasis Market Restraints
11.3 Global Psoriasis Market Trends
12. Market Attractiveness
12.1.1 Market Attractiveness Chart of Global Psoriasis Treatment Market – By Type (Year 2025)
12.1.2 Market Attractiveness Chart of Global Psoriasis Market – By Treatment Method (Year 2025)
12.1.3 Market Attractiveness Chart of Global Psoriasis Treatment Market – By Region, By Value, (Year-2025)
13. Competitive Landscape
13.1 Psoriasis Pipeline Analysis
13.2 Market Share Analysis
14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
14.1 UCB
14.2 Sun Pharmaceutical Industries Ltd.
14.3 Boehringer Ingelheim
14.4 Almirall
14.5 Bausch Health
14.6 Abbvie Inc.
14.7 Eli Lilly and Company
14.8 Pfizer Inc.
14.9 Amgen Inc.
14.10 Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/r/lfp8z9
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900